v3.19.1

Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Current Assets
Cash	$ 206	$ 86
Restricted cash	0	303
Trade accounts receivable, net	1,585	1,673
Other receivables	218	345
Receivable from affiliates	0	6
Inventories, net	2,854	3,562
Prepaid expenses	77	267
Total current assets	4,940	6,242
Long term receivable	472	448
Property and equipment, net	956	1,045
Intangible assets, net	2,389	2,892
Deferred tax asset	0	2,000
Total assets	8,757	12,627
Current Liabilities
Accounts payable	2,896	3,123
Accrued liabilities	483	429
Notes payable, current portion	1,326	813
Revolving credit facility	3,956	3,831
Total current liabilities	8,661	8,196
Notes payable, long-term portion	1,653	2,801
Total liabilities	10,314	10,997
Stockholders' equity:
Preferred stock, $0.0001 par value; 7,500,000 shares authorized: none issued and outstanding	0	0
Common stock, $0.0001 par value; 50,000,000 shares authorized; 24,112,164 shares issued and 23,082,164 shares outstanding at September 30, 2018; 24,003,310 shares issued and 22,973,310 shares outstanding at December 31, 2017	2	2
Additional paid-in capital	60,214	60,221
Accumulated deficit	(61,376)	(58,196)
Treasury stock, at cost, 1,030,000 shares	(397)	(397)
Total stockholders' equity	(1,557)	1,630
Total liabilities and stockholders' equity	$ 8,757	$ 12,627

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Dougherty's Pharmacy, Inc. 10-Q